New Medtronic Robot Faces Manufacturing Challenges

Medtronic hit a major milestone in surgical robotics last month when it received a CE mark for the Hugo robotic-assisted surgery system. It seems the company has experienced a slight setback, however, which will delay its broader commercial launch of Hugo.

During Medtronic's Q2 2022 earnings call Tuesday, CEO Geoff Martha revealed that the company has encountered some supply chain issues and some initial manufacturing issues during the limited release phase of the robotics platform, which will mean Hugo revenue for the fiscal year will come in below target. Martha said the company is focused on working through those issues, and making sure that the initial surgeon experiences with the technology are positive.